PLoS ONE (Jan 2022)

Association between cigarette smoking and ovarian reserve among women seeking fertility care

  • Islamiat Oladipupo,
  • T’shura Ali,
  • David W. Hein,
  • Kelly Pagidas,
  • Henry Bohler,
  • Mark A. Doll,
  • Merry Lynn Mann,
  • Adrienne Gentry,
  • Jasmine L. Chiang,
  • Rebecca C. Pierson,
  • Sashia Torres,
  • Emily Reece,
  • Kira C. Taylor

Journal volume & issue
Vol. 17, no. 12

Abstract

Read online

Introduction This study examined the association of smoking with ovarian reserve in a cross-sectional study of 207 women enrolled in the Louisville Tobacco Smoke Exposure, Genetic Susceptibility, and Infertility (LOUSSI) Study and assessed effect modification by NAT2 acetylator phenotype. Methods Information on current smoking status was collected using a structured questionnaire and confirmed by cotinine assay. Serum anti-Müllerian hormone (AMH) levels were used to assess ovarian reserve. Diminished ovarian reserve (DOR) was defined as AMH Results Current smoking status, either passive or active as measured by urinary cotinine assay, was not significantly associated with DOR. For dose-response assessed using self-report, the odds of DOR increased significantly for every additional cigarette currently smoked (Odds ratio, OR:1.08; 95% confidence interval, 95%CI:1.01–1.15); additionally, every 1 pack-year increase in lifetime exposure was associated with an increased odds of DOR among women without PCOS (OR: 1.08 95%CI: 0.99–1.18). These trends appear to be driven by the heavy or long-term smokers. Effect modification by NAT2 genotype was not established. Conclusion A history of heavy smoking may indicate increased risk of diminished ovarian reserve.